
December 23, 2024
CD40L-augmented tumor infiltrating lymphocyte expa...
Lilit Karapetyan’s Abstract Tumor infiltrating lymphocyte (TIL) therapy represents a promising approach for the treatment of patients whose disease does not benefit f...
Learn more about our upcoming Galas and Signature Events Learn More
Superyacht Captain, TV Personality, Melanoma Patient and Advocate Poised to Emcee Event Honoring the Melanoma Community New York City, NY (September 11, 2025) – The...
Lilit Karapetyan’s Abstract Tumor infiltrating lymphocyte (TIL) therapy represents a promising approach for the treatment of patients whose disease does not benefit f...
Alexander Huang’s Abstract Radiation can be used as a vaccine, to increase the effect of immunotherapy. We call this Radvax, which is promising. Even in melanoma pati...
Pilot Proposal – Keiran Smalley, PhD
Oct 16, 2025 ET
Oct 30, 2025 ET